Skip to content

Clinical observation on the treatment of perimenopausal dry eye with the method of benefiting kidney and soothing liver

Clinical observation on the treatment of perimenopausal dry eye with the method of benefiting kidney and soothing liver

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026940
Enrollment
Unknown
Registered
2019-10-27
Start date
2019-10-24
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye disease

Interventions

treatment group:Erxian and Chaihu Decoction

Sponsors

Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) women aged 40-55 meet the diagnostic criteria of perimenopause. (2) according with the diagnosis of dry eye. (3) patients with liver depression and kidney deficiency are characterized by dizziness of head, depression of chest, less sleep and more dreams, hot sweating, anxiety and depression, irritability and weakness of waist and knees.

Exclusion criteria

Exclusion criteria: (1) other ocular organic diseases. (2) have a history of eye surgery. (3) combined with systemic immune diseases and brain and nervous system diseases. (4) unable to cooperate with the required inspections.

Design outcomes

Primary

MeasureTime frame
Dry eye comprehensive analyzer;Lipi View;OSDI;

Secondary

MeasureTime frame
Lacrimal inflammatory factor;

Countries

China

Contacts

Public ContactJing Yu

Beijing Tongren Hospital, Capital Medical University

yujing0311@163.com+86 13581999763

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026